Astrantus »

West Pharmaceutical Services shares owned by Astrantus

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $205k 500 410.00

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Artisan Partners Limited Partnership
Brown Advisory Holdings Incorporated
Geode Capital Management
Morgan Stanley
Van Eck Associates Corp.
APG All Pensions Group NV
Durable Capital Partners
Kayne Anderson Rudnick Investment Management
Generation Investment Management
Franklin Resources
Ubs Global Asset Management Americas

View all funds holding West Pharmaceutical Services